TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS EGX:RMDA:
EGYPT'S RAMEDA FY CONSOL NET PROFIT EGP 313.2 MILLION
RAMEDA FY CONSOL REVENUE EGP 4.10 BILLION
Rameda FY Consol Profit EGP 313.2 Million
Earlier from Tenth Of Ramadan Pharmaceutical Industries & Diagnostic-rameda
- LVP Pharma Raises Stake In RAMEDA To 23.15% - EGX
- LVP Pharma Raises Stake In RAMEDA To 11.8% - EGX
- Egypt's Rameda Q3 Income EGP 96 Mln
- Egypt's Rameda Borad Proposes To Increase Issued Capital